As Chief Financial Officer, Tony is responsible for developing and leading short, medium, and long-term financial strategies aimed at driving sustainable growth while ensuring that at all times our focus remains on the best possible outcomes for our clients, sponsors, patients, employees, and the community in general.

Tony holds a Bachelor of Accounting and has held senior leadership positions in finance and a Board appointment within the Pharmaceutical and Contract Research sectors within multi-national organisations since 2008. With over 20 years of experience within the CRO sector servicing clients across Asia Pacific, Japan, China, India, Europe, and the United States, Tony brings a wealth of knowledge to Grand Pacific CRO from day-to-day operational and project finance management through to corporate strategy, governance, and compliance.

Grainne brings over 20 years of Human Resource experience to Grand Pacific CRO. As Global VP HR Grainne is responsible for driving the HR strategy to support our employees across 8 countries across the globe.

Grainne is focused on helping the Organisation offer the very best experiences for employees, and that Grand Pacific CRO’s culture is anchored in our values. She is also committed to promoting employee well-being and supporting an inclusive and diverse workforce.

Grainne is a seasoned executive who deeply knows and understands the ‘People’ part of growing businesses, bringing a refreshing focus to the workplace culture, employee development, and satisfaction
Prior to joining GP CRO, Grainne has experience building successful HR functions for various start-ups and has also held HR Senior Management roles at Deloitte and other institutions such as Commonwealth Bank of Australia and Westpac.

Thidarat brings over 15 years of Quality Assurance experience to Grand Pacific CRO.  As a Global Quality Assurance Director, Thidarat is responsible for driving the quality assurance programs at a global level. Provide direction in support of customer and functional accounts, audit and inspection programs, and quality management systems. Provide insights, analyses, and support in the promotion and assessment of compliance with regulations, guidelines, and operating procedures within the globally assigned.

Thidarat is a pharmacist by education.  She has held leadership positions in quality assurance with multinational pharmaceutical companies for a number of years.  She has extensive quality assurance experience in both clinical research and marketed products at a global level and a country level.  She has been a qualified lead auditor conducting GCP audits including contracted clinical investigator site audits and other GxP audits such as GMP, GDP, GVP and GLP audits for 10 years and hosting client audits, and facilitating a number of regulatory inspections with a satisfactory level of compliance.

As Group General Counsel, Nikolina is responsible for leading the legal, risk, and compliance functions of our business.

Nikolina brings over 20 years of experience to the role, gained from working across diverse industries including technology, energy, aviation, and life science. She has previously worked for top-tier law firms in the UK and Australia and has led in-house legal functions for companies with a strong Asia Pacific and global presence.

With extensive multi-jurisdictional experience, Nikolina delivers comprehensive legal support for our business operations globally. As a strong business enabler, she leads a team that supports business growth through streamlined systems and processes, while ensuring quality is maintained and risk is identified, managed, and mitigated.

With dual qualifications in law and biomedical science, Nikolina navigates the biomedical life science industry with ease and collaborates closely with the scientific and clinical divisions of our business.

Tony is an experienced pharmaceutical professional with skills in Medicine Information Optimisation, Regulatory Affairs, Sales, and Marketing from global pharmaceutical companies, including Eli Lilly, GSK, Mylan, Phebra, and Pharmaxis. He has wide-ranging experience in writing and developing product Information/SmPC, consumer medicine information/package leaflet, minimum PI, instruction manual, and labelling to ensure a high level of quality, consistency, and compliance with the local and international regulatory requirements. Tony majors in Medical Microbiology & Immunology and Pharmacology and has a Master’s degree in Drug Development/Pharmaceutical Medicine. Due to his passion for medical writing, he has also pursued a PhD in developing and optimising written medicine information for prescription medicines.

Tony is responsible for providing medical writing expertise and oversight to all medical writing documents for GPCRO, such as manuscript, clinical trial protocol, participant information consent form, investigator’s brochure, pharmacy manual, and clinical study report in alignment with the requirements of GCP and ICH guidance. He utilises his experience and skills to positively impact project deliverables, develop scopes, bring innovation, build excellent relationships with internal and external stakeholders, and provide critical thinking to all aspects of planning and executing.